Can we make science as fast as software? In this episode, Erik Torenberg talks with Patrick Hsu (cofounder of Arc Institute) and a16z general partner Jorge Conde about Arc’s “virtual cells” moonshot, which uses foundation models to simulate biology and guide experiments.
Today
Chris Dixon: From Quant Trading to Building a16z Crypto
In this feed drop from the Internet History Podcast, host Brian McCullough speaks with Chris Dixon, general partner at a16z, about his path from 1980s hobbyist programmer to one of the most prominent venture capitalists in tech. Chris traces his career from quantitative finance t ... Show More
59m 33s
Feb 27
a16z's New Media Playbook
Erik Torenberg, Ben Horowitz, and Marc Andreessen discuss how the media landscape has fundamentally changed and what a16z is doing about it. They cover why offense beats defense, why individuals now matter more than corporate brands, why speed wins in the new media landscape, and ... Show More
48m 28s
Feb 26
When Giants Don’t Go Public: Inside the $5 Trillion Private Tech Market
Bloomberg's Odd Lots hosts Joe Weisenthal and Tracy Alloway speak with David George, general partner at a16z and head of the firm's growth fund, about why $5 trillion in tech market cap now sits in the private markets, how that figure has grown 10x in a decade, and what it means ... Show More
47m 1s
Feb 2025
Virtual Cell Models, Tahoe-100 and Data for AI-in-Bio with Vevo Therapeutics and the Arc Institute
On this week’s episode of No Priors, Sarah Guo is joined by leading members of the teams at Vevo Therapeutics and the Arc Institute – Nima Alidoust, CEO/Co-Founder at Vevo Therapeutics; Johnny Yu, CSO/Co-Founder at Vevo Therapeutics; Patrick Hsu, CEO/Co-Founder at Arc Institute; ... Show More
57m 40s
Nov 2025
How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara
Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ... Show More
48m 13s
Sep 2025
Value-Based Oncology at Scale: Inside Thyme Care
<p>Cancer care in the U.S. costs over $250 billion each year, and nearly 2 million Americans receive a new diagnosis annually, yet too often the journey begins with silence: no call, no plan, no guide.</p><p>In this episode, a16z’s Vineeta Agarwala and Jay Rughani talk with Thyme ... Show More
41m 16s
Nov 2024
833: The 10 Reasons AI Projects Fail, with Dr. Martin Goodson
Martin Goodson speaks to Jon Krohn about what he would add to his viral article “Ten Ways Your Data Project is Going to Fail”, why practitioners always need to be present at AI policy discussions, and Evolution AI’s breakthroughs in computer vision and NLP.
This episode is broug ... Show More
1h 25m
<p><strong>Natural First-Aid Healing: </strong><a href="https://" rel="noopener noreferrer" target="_blank">https://</a><a href="https://3rdrockessentials.com/" rel="noopener noreferrer" target="_blank">3rdrockessentials.com</a>, use code <strong>DAVE</strong>  ... Show More
